SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-036513
Filing Date
2024-09-16
Accepted
2024-09-16 21:58:06
Documents
1
Period of Report
2024-09-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1497
  Complete submission text file 0001493152-24-036513.txt   2902
Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Issuer) CIK: 0001834105 (see all company filings)

IRS No.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1216 ELLIOTT LANE PRINCETON IL 61356
Business Address
Sims Melissa Kaye (Reporting) CIK: 0002007683 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42212 | Film No.: 241302400